CXCL1 and hepatocellular carcinoma: As shown in Figure 7(a), after treatment with belinostat for 24 h, a significant increase in CXCL1 mRNA expression was induced in BT-549, MDA-MB-231, and HCC-1937, especially BT-549 cells.